Dr Reddys to acquire OctoPlus for Rs 192 crore

0
515

Oct 23, 2012: Leading Indian pharma firm, Dr Reddys Labs  has decided to buy the stake of Dutch injectable specialty generics manufacturer OctoPlus NV for Rs 192 crore. DRL sources stated that the expertise of OctoPlus in making injectable drugs based on proprietary technologies will compliment their market offerings.

LEAVE A REPLY

Please enter your comment!
Please enter your name here